Blog

Be Your Best in 2016 by Focusing on First Things First

The New Year is a great time to reflect on the big questions of life like, Who Am I? Why Am I Here? What Is My Purpose? What Should I Do Next? While we at Obagi love to talk about how to look your best, we also know how critically important it is to BE your best.

In the Spirit of BEING your best in 2016, we’ve put together this mini workbook to help you think about priorities. Often overlooked is the necessity to put “first things first” in life; to work out what our priorities are, and how much time and energy we’re spending each day on things that matter (high priority items), and things that don’t (low priority items).

Ask yourself, how do the areas listed below rank in terms of importance to you? Rank them in order of importance from 1-8 (1 is the most important thing in life to you, and 8 is the least important.) After you rank them, consider how much time and effort you place on each area currently. Does the time and effort reflect the prioritization of: Are you living life according your priorities? There is no right or wrong answer; this is all about Y-O-U, and being your best in 2016 by focusing on First Things First.

Original Family: This includes parents, siblings, aunts and uncles. Those with whom you grew up.

Adult Family: Your spouse, your children, your significant other.

Close Friends: Those who you know “have your back,” and can count on to be there when you need it.

Acquaintances: Not close friends, but people you like and want to spend time with.

Work: Your career, the way you make your money.

Health: This can include exercise, healthy eating, physician and dental care… anything that takes care of your physical well-being.

Spirituality: Your connection with a Higher Power. Or your connection with something outside yourself. Whereas “health” deals with physical well-being, this area deals with emotional and spiritual well-being.

Fun: Play, relaxation, “recharge” time.

How did you rank these areas in your life? Are you putting first things first already, or do you have some re-prioritization to do in life? Comment below.

®/TMs are trademarks of Valeant Pharmaceuticals International, Inc. or its affiliates. All other product or brand names are trademarks of their respective owners. Distributed by Obagi Medical Products, a division of Valeant Pharmaceuticals North America LLC.

Find Obagi Products

Sign up to receive exclusive emails for first-look access to new Obagi products, expert skin care tips and advice, special promotions, and more!

All fields required

First Name *

Email *

Are you a U.S. Resident? *

Yes

No

Zip Code *

Obagi will never sell, rent, or share your personal information with any third parties for marketing purposes without your express permission. By submitting your information, you confirm you have read and agree with the terms of our Privacy Policy.

Stay Connected With Obagi

Obagi Premier Points®

Earn points every time you purchase participating Obagi products from your physician. Join today and redeem accumulated points for free Obagi products in the future. Terms and conditions apply. Download the app to see full terms and conditions.

Obagi Systems and Products are physician-dispensed and should be used only under the guidance of your skin care physician. Please be advised that certain products have limited distribution and may not be available in your area. Please contact your Obagi skin care physician for more information.

Important Safety Information for Obagi Nu-Derm Clear and Blender®

(contains 4% hydroquinone)

CONTRAINDICATIONS:
People with prior history of sensitivity or allergic reaction to this product or any of its ingredients should not use it. The safety of topical hydroquinone use during pregnancy or in children (12 years and under) has not been established.

WARNINGS:
Avoid contact with eyes, nose, mouth, or lips. In case of accidental contact, patient should rinse eyes, nose, mouth, or lips with water and contact physician.

Sunscreen use is an essential aspect of hydroquinone therapy because even minimal sunlight exposure sustains melanocytic activity.

Contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people.

PRECAUTIONS (ALSO SEE WARNINGS):
Treatment should be limited to relatively small areas of the body at one time since some patients experience a transient skin reddening and a mild burning sensation, which does not preclude treatment.

Pregnancy Category C: Animal reproduction studies have not been conducted with topical hydroquinone. It is also not known whether hydroquinone can cause fetal harm when used topically on a pregnant woman or affect reproductive capacity. It is not known to what degree, if any, topical hydroquinone is absorbed systemically. Topical hydroquinone should be used on pregnant women only when clearly indicated.

Nursing Mothers: It is not known whether topical hydroquinone is absorbed or excreted in human milk. Caution is advised when topical hydroquinone is used by a nursing mother.

Pediatric Usage: Safety and effectiveness in children below the age of 12 years have not been established.

Use of the product should be discontinued if hypersensitivity to any of the ingredients is noted.

CONTRAINDICATIONS:
People with prior history of sensitivity or allergic reaction to this product or any of its ingredients should not use it. The safety of topical hydroquinone use during pregnancy or in children (12 years and under) has not been established.

WARNINGS:
Avoid contact with eyes, nose, mouth, or lips. In case of accidental contact, patient should rinse eyes, nose, mouth, or lips with water and contact physician.

Sunscreen use is an essential aspect of hydroquinone therapy because even minimal sunlight exposure sustains melanocytic activity.

Contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people.

PRECAUTIONS (ALSO SEE WARNINGS):
Treatment should be limited to relatively small areas of the body at one time since some patients experience a transient skin reddening and a mild burning sensation, which does not preclude treatment.

Pregnancy Category C: Animal reproduction studies have not been conducted with topical hydroquinone. It is also not known whether hydroquinone can cause fetal harm when used topically on a pregnant woman or affect reproductive capacity. It is not known to what degree, if any, topical hydroquinone is absorbed systemically. Topical hydroquinone should be used on pregnant women only when clearly indicated.

Nursing Mothers: It is not known whether topical hydroquinone is absorbed or excreted in human milk. Caution is advised when topical hydroquinone is used by a nursing mother.

Pediatric Usage: Safety and effectiveness in children below the age of 12 years have not been established.

Use of the product should be discontinued if hypersensitivity to any of the ingredients is noted.

CONTRAINDICATIONS:
People with prior history of sensitivity or allergic reaction to this product or any of its ingredients should not use it. The safety of topical hydroquinone use during pregnancy or in children (12 years and under) has not been established.

WARNINGS:
Avoid contact with eyes, nose, mouth, or lips. In case of accidental contact, patient should rinse eyes, nose, mouth, or lips with water and contact physician.

Sunscreen use is an essential aspect of hydroquinone therapy because even minimal sunlight exposure sustains melanocytic activity.

Contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people.

PRECAUTIONS (ALSO SEE WARNINGS):
Treatment should be limited to relatively small areas of the body at one time since some patients experience a transient skin reddening and a mild burning sensation, which does not preclude treatment.

Pregnancy Category C: Animal reproduction studies have not been conducted with topical hydroquinone. It is also not known whether hydroquinone can cause fetal harm when used topically on a pregnant woman or affect reproductive capacity. It is not known to what degree, if any, topical hydroquinone is absorbed systemically. Topical hydroquinone should be used on pregnant women only when clearly indicated.

Nursing Mothers: It is not known whether topical hydroquinone is absorbed or excreted in human milk. Caution is advised when topical hydroquinone is used by a nursing mother.

Pediatric Usage: Safety and effectiveness in children below the age of 12 years have not been established.

Use of the product should be discontinued if hypersensitivity to any of the ingredients is noted.